Kontraindikationer, interaktioner der kræver dosisjustering og omhyggelig klinisk og/ eller 68 biologisk monitorering, og til sidst dem der ingen signifikant farmakokinetisk interaktion har, men som har klinisk interesse for det terapeutiske område.
The interactions for the first two sections are presented in the following order: contraindications, those requiring dosage adjustment and careful clinical and/ or biological monitoring and finally those that have no significant pharmacokinetic interaction but may be of clinical interest in this therapeutic field.